| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Dec―12 |
Protocol to isolate broadly neutralizing monoclonal antibodies against SARS-CoV-2 from human B cells |
Xueyan Huang, Maosheng Lu, Ling Li, Zuowei Wang, Yunjian Li, Xixian Chen, Yi Sun, Ruiping Du, Rongrong Qin, Lin Hu, Yucong Sun, Liwei Jiang, Teng Zuo |
| 2 |
[GO] |
2025―Jul―18 |
Protocol for production and characterization of SARS-CoV-2 PLpro in Escherichia coli |
Anna De Falco, Rebecca Greene-Cramer, Ben A. Shurina, Suren Zakian, Thomas B. Acton, Theresa A. Ramelot, Gaetano T. Montelione |
| 3 |
[GO] |
2025―Mar―05 |
Protocol for processing multivariate time-series electronic health records of COVID-19 patients |
Zixiang Wang, Yinghao Zhu, Dehao Sui, Tianlong Wang, Yuntao Zhang, Yasha Wang, Chengwei Pan, Junyi Gao, Liantao Ma, Ling Wang, Xiaoyun Zhang |
| 4 |
[GO] |
2025―Jan―15 |
Protocol for evaluating humoral immune responses in mice following SARS-CoV-2 vaccination |
Yao Zhang, Shixiong Li, Jingyou Yu |
| 5 |
[GO] |
2025―Jan―08 |
Protocol for investigating intracellular microbial diversity using single-cell RNA-seq in immune cells of SARS-CoV-2-positive and recovered patients |
Jyoti Soni, Priyanka Mehta, Sunita Yadav, Partha Chattopadhyay, Rajesh Pandey |
| 6 |
[GO] |
2024―Jul―30 |
Protocol to search for genetic factors related to severe COVID-19 by analyzing publicly available genome-wide association studies |
Ke Zhang, Siyu Lin, Yu-si Luo, Zhongshan Cheng |
| 7 |
[GO] |
2024―Jun―20 |
Protocol for the creation and characterization of SARS-CoV-2 variant testing panels using remnant clinical samples for diagnostic assay testing |
Leda Bassit, Heather B. Bowers, Morgan Greenleaf, Courtney Sabino, Eric Lai, Grace Yu, Anne Piantadosi, Ethan Wang, William O’Sick, Kaleb McLendon, Julie A. Sullivan, Raymond F. Schinazi, Gregory L. Damhorst, Wilbur Lam, Anuradha Rao |
| 8 |
[GO] |
2024―May―19 |
Protocol to decode the role of transcriptionally active microbes in SARS-CoV-2-positive patients using an RNA-seq-based approach |
Aanchal Yadav, Priti Devi, Pallawi Kumari, Ranjeet Maurya, Uzma Shamim, Rajesh Pandey |
| 9 |
[GO] |
2024―Apr―09 |
Protocol to longitudinally quantify SARS-CoV-2 RNA in wastewater using RT-qPCR and pepper mild mottle virus normalization |
Bryan Sanchez Jimenez, Trinity Sterling, Austin Brown, Brian Modica, Kaylee Gibson, Hannah Collins, Carolyn Koch, Tyler Schwarz, Kristine N. Dye |
| 10 |
[GO] |
2024―Apr―06 |
Protocol to identify flavonoid antagonists of the SARS-CoV-2 main protease |
Moua Yang, Lin Lin, Robert Flaumenhaft |
| 11 |
[GO] |
2024―Feb―23 |
Chemical inactivation strategies for SARS-CoV-2-infected cells and organoids |
Marwah Karim, Amol Arunrao Pohane, Chieh-Wen Lo, Shirit Einav, Jaishree Garhyan |
| 12 |
[GO] |
2024―Jan―04 |
Protocol for training MERGE: A federated multi-input neural network for COVID-19 prognosis |
Bruno Casella, Walter Riviera, Marco Aldinucci, Gloria Menegaz |
| 13 |
[GO] |
2023―Sep―21 |
Protocol to detect infectious SARS-CoV-2 at low levels using in situ hybridization techniques |
Andréa Cottignies-Calamarte, Feifan He, Aiwei Zhu, Fernando Real, Morgane Bomsel |
| 14 |
[GO] |
2023―Sep―21 |
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses |
Camilla Tiezzi, Marzia Rossi, Andrea Vecchi, Sara Doselli, Amalia Penna, Paola Fisicaro, Ilaria Montali, Camilla Ceccatelli Berti, Valentina Reverberi, Anna Montali, Gabriele Missale, Carlo Ferrari, Carolina Boni |
| 15 |
[GO] |
2023―Jun―12 |
Protocol for studying co-infection between SARS-CoV-2 and Staphylococcus aureus in vitro |
Mariya I. Goncheva, David E. Heinrichs |
| 16 |
[GO] |
2023―May―15 |
Protocol to isolate temperature-sensitive SARS-CoV-2 mutants and identify associated mutations |
Shinya Okamura, Akiho Yoshida, Paola Miyazato, Mai Matsumoto, Hirotaka Ebina |
| 17 |
[GO] |
2023―May―05 |
Protocol for production and purification of SARS-CoV-2 3CLpro |
Luca Mazzei, Rebecca Greene-Cramer, Khushboo Bafna, Aleksandar Jovanovic, Anna De Falco, Thomas B. Acton, Catherine Ann Royer, Stefano Ciurli, Gaetano T. Montelione |
| 18 |
[GO] |
2023―May―04 |
FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 Mpro and PLpro |
Haozhou Tan, Yanmei Hu, Jun Wang |
| 19 |
[GO] |
2023―Apr―27 |
Protocol for infecting and monitoring susceptible k18-hACE2 mice with SARS-CoV-2 |
Joana Couto, Rute Gonçalves, Sofia Lamas, Margarida Saraiva |
| 20 |
[GO] |
2023―Apr―24 |
Protocol for in vitro fluorescence assay of papain-like protease and cell-based immunofluorescence assay of coronavirus infection |
JuOae Chang, Jinhee Kim, Subin Hong, Kwiwan Jeong, Seungtaek Kim, Wonsik Lee |
| 21 |
[GO] |
2023―Mar―06 |
A cell-free platform to measure coronavirus membrane fusion |
Thomas Kicmal, Enya Qing, Grant M Hawkins, Alexandria Wilcox, Tom Gallagher |
| 22 |
[GO] |
2023―Feb―27 |
Immunization of MERS-CoV-2-infected mice with a sublethal dose of MERS-CoV or VRP-MERS-S |
Jian Zheng, Rudra Channapannavar, Stanley Perlman |
| 23 |
[GO] |
2023―Feb―10 |
Inhibition of SARS-CoV-2 Infection in Cellular Systems Using Engineered Trimeric Receptor Binding Domain of Spike Protein |
Angela Rose Liu, Shrikanth C. Basavarajappa, Nandini Sarkar, Anna Bruchez, Parameswaran Ramakrishnan |
| 24 |
[GO] |
2023―Feb―09 |
B-cell ELISpot assay to analyze human memory B cell and plasmablast responses specific to SARS-CoV-2 Receptor Binding Domain |
Angeline Rouers, Matthew Zirui Tay, Lisa FP. Ng, Laurent Renia |
| 25 |
[GO] |
2023―Jan―17 |
Protocol to evaluate the inflammatory response in human macrophages induced by SARS-CoV-2 spike-pseudotyped VLPs |
Maggie Jing Ouyang, Zhujun Ao, Titus A. Olukitibi, Xiao-Jian Yao |
| 26 |
[GO] |
2022―Dec―15 |
Protocol for investigating the biogenesis of SARS-CoV2-S pseudoviruses in HEK293T cells transduced to express the virus-specific intrabodies |
Surbhi Dahiya, Sudhakar Singh, Sharvan Sehrawat |
| 27 |
[GO] |
2022―Nov―16 |
Flow cytometric protocol to characterize human memory B cells directed against SARS-CoV-2 spike protein antigens |
Leonie M. Weskamm, Christine Dahlke, Marylyn M. Addo |
| 28 |
[GO] |
2022―Nov―07 |
Protocol for SARS-CoV-2 infection of kidney organoids derived from human pluripotent stem cells |
Elena Garreta, Daniel Moya-Rull, Megan L. Stanifer, Vanessa Monteil, Patricia Prado, Andrés Marco, Carolina Tarantino, Maria Gallo, Gustav Jonsson, Astrid Hagelkruys, Ali Mirazimi, Steeve Boulant, Josef M. Penninger, Nuria Montserrat |
| 29 |
[GO] |
2022―Oct―28 |
Characterization of multiple interactions between the envelope E protein of SARS-CoV-2 and human BRD4 |
Mohamad Zandian, Suk Min Jang, Catherine Lachance, Arpan Acharya, Siddappa N. Byrareddy, Jacques Côté, Tatiana G. Kutateladze |
| 30 |
[GO] |
2022―Oct―24 |
Protocol to assess human germinal center responses to SARS-CoV-2 vaccination using a combined fine needle aspiration and spectral flow cytometry approach |
Emily Bettini, Katlyn Lederer, Hannah Sharpe, Mary Kaminski, Lisa Jones, Michela Locci |
| 31 |
[GO] |
2022―Oct―19 |
A high throughput SARS-CoV-2 pseudovirus multiplex neutralization assay |
Benjamin Louis Sievers, Terri Gelbart, Gene S. Tan |
| 32 |
[GO] |
2022―Oct―04 |
Protocol for characterizing the inhibition of SARS-CoV-2 infection by a protein of interest in cultured cells |
Xinyuan Lai, Hui Zhuang, Tong Li, Kuanhui Xiang |
| 33 |
[GO] |
2022―Oct―03 |
Protocol for high-throughput screening of SARS-CoV-2 main protease inhibitors using a robust fluorescence polarization assay |
Jing Zhang, Haohao Yan, Gangan Yan, Xiaoping Liu, Yanchang Wang, Yunyu Chen |
| 34 |
[GO] |
2022―Sep―26 |
Protocol to quantify and phenotype SARS-CoV-2 specific T-cell response using a rapid flow cytometry-based whole blood assay |
Hygon Mutavhatsindi, Catherine Riou |
| 35 |
[GO] |
2022―Sep―26 |
Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike protein-mediated membrane fusion assay |
Hesham Nasser, Ryo Shimizu, Jumpei Ito, Akatsuki Saito, Kei Sato, Terumasa Ikeda |
| 36 |
[GO] |
2022―Aug―26 |
SARS-CoV-2 CD8+ T cell killing assays using replicating viruses and transgenic antigens |
Laura M. Mateyka, Vincent Grass, Andreas Pichlmair, Dirk H. Busch, Elvira D’Ippolito |
| 37 |
[GO] |
2022―Aug―04 |
Protocol for high throughput screening of ACE2 enzymatic activators to treat COVID-19 induced metabolic complications |
Pin Chen, Chenshu Liu, Zhongyu Zhang, Zilun Li, Sifan Chen, Yutong Lu |
| 38 |
[GO] |
2022―Aug―03 |
Protocol to identify host-viral protein interactions between coagulation-related proteins and their genetic variants with SARS-CoV-2 proteins |
David D. Holcomb, Katarzyna I. Jankowska, Nancy Hernandez, Kyle Laurie, Jacob Kames, Nobuko Hamasaki-Katagiri, Anton A. Komar, Michael DiCuccio, Chava Kimchi-Sarfaty |
| 39 |
[GO] |
2022―Jul―21 |
Infecting kidney organoids with a cDNA reporter clone of SARS-CoV-2 |
Hyunjae Chung, Maxwell P. Bui-Marinos, Waleed Rahmani, Jennifer A. Corcoran, Justin Chun |
| 40 |
[GO] |
2022―Jul―19 |
Using human iPSC-derived kidney organoids to decipher SARS-CoV-2 pathology on single cell level |
Katharina C. Reimer, Jitske Jansen, Gijs J. Overheul, Pascal Miesen, Ronald P. van Rij, Sergio H. Triana, Bart Smeets, Rebekka K. Schneider, Rafael Kramann |
| 41 |
[GO] |
2022―Jul―15 |
Transient Transfection and Purification of SARS-CoV-2 Spike Protein from Mammalian cells |
Victoria Stalls, Katarzyna Janowska, Priyamvada Acharya |
| 42 |
[GO] |
2022―Jun―13 |
Protocol to isolate and assess spike protein cleavage in SARS-CoV-2 variants obtained from clinical COVID-19 samples |
Alba Escalera, Adolfo García-Sastre, Teresa Aydillo |
| 43 |
[GO] |
2022―May―24 |
SPIKES: Identification of physicochemical properties of spike proteins across diverse host species of SARS-CoV-2 |
Srinivasulu Yerukala Sathipati, Ming-Ju Tsai, Tonia Carter, Sanjay K. Shukla, Shinn-Ying Ho |
| 44 |
[GO] |
2022―May―02 |
An antibody-based proximity labeling protocol to identify biotinylated interactors of SARS-CoV-2 |
Limin Shang, Yuehui Zhang, Yuchen Liu, Chaozhi Jin, Yanan Zhao, Jing Zhang, Pei-Hui Wang, Jian Wang |
| 45 |
[GO] |
2022―Apr―22 |
Real-time cell analysis: A high-throughput approach for testing SARS-CoV-2 antibody neutralization and escape |
Naveenchandra Suryadevara, Pavlo Gilchuk, Seth J. Zost, Nikhil Mittal, Li Leyna Zhao, James E. Crowe, Robert H. Carnahan |
| 46 |
[GO] |
2022―Apr―22 |
Protocols for SARS-CoV-2 infection in primary ocular cells and eye organoids |
Anne Zebitz Eriksen, Rasmus Møller, Bar Markovoz, Benjamin R. tenOever, Timothy A. Blenkinsop |
| 47 |
[GO] |
2022―Apr―21 |
Analyzing single cell transcriptome data from severe COVID-19 patients |
Nasna Nassir, Richa Tambi, Asma Bankapur, Noushad Karuvantevida, Hamdah Hassan Khansaheb, Binte Zehra, Ghausia Begum, Reem Abdel Hameid, Awab Ahmed, Zulfa Deesi, Abdulmajeed Alkhajeh, K M Furkan Uddin, Hosneara Akter, Seyed Ali Safizadeh Shabestari, Mellissa Gaudet, Mahmood Yaseen Hachim, Alawi Alsheikh-Ali, Bakhrom K. Berdiev, Saba Al Heialy, Mohammed Uddin |
| 48 |
[GO] |
2022―Mar―22 |
An economical and sensitive glassmilk-based nucleic-acid extraction approach for SARS-CoV-2 diagnostics |
Robert Page, Edward Scourfield, Mattia Ficarelli, Stuart McKellar, Kwok Leung Lee, Thomas J.A. Maguire, Clement Bouton, Maria Jose Lista, Stuart J.D. Neil, Michael H. Malim, Mark Zuckerman, Hannah E. Mischo, Rocio T. Martinez-Nunez |
| 49 |
[GO] |
2022―Mar―03 |
A computational protein design protocol for optimization of the SARS-CoV-2 receptor-binding-motif affinity for human ACE2 |
Savvas Polydorides, Georgios Archontis |
| 50 |
[GO] |
2022―Mar―02 |
Open access methods and protocols promote open science in a pandemic |
Emily Marcinkevicius, Matthew J. Pavlovich |
| 51 |
[GO] |
2022―Feb―28 |
SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling |
Dan-yun Lai, He-wei Jiang, Yang Li, Hai-nan Zhang, Sheng-ce Tao |
| 52 |
[GO] |
2022―Feb―22 |
A cell-based system combined with flow cytometry to evaluate antibody responses against SARS-CoV-2 transmembrane proteins in patients with COVID-19 |
Sophie Martin, Gwénaële Jégou, Aurore Nicolas, Matthieu Le Gallo, Éric Chevet, Florence Godey, Tony Avril |
| 53 |
[GO] |
2022―Feb―02 |
Mass spectrometry and proteome analysis to identify SARS-CoV-2 protein from COVID-19 patient swab samples |
Arghya Banerjee, Medha Gayathri J Pai, Avinash Singh, Mehar Un Nissa, Sanjeeva Srivastava |
| 54 |
[GO] |
2022―Jan―24 |
Protocol for Structure Determination of SARS-CoV-2 Main Protease at Near-physiological-temperature by Serial Femtosecond Crystallography |
Fatma Betul Ertem, Omur Guven, Cengizhan Buyukdag, Oktay Gocenler, Esra Ayan, Busra Yuksel, Mehmet Gul, Gozde Usta, Barıs Cakılkaya, J. Austin Johnson, E. Han Dao, Zhen Su, Frederic Poitevin, Chun Hong Yoon, Christopher Kupitz, Brandon Hayes, Mengning Liang, Mark S. Hunter, Alexander Batyuk, Raymond G. Sierra, Gihan Ketawala, Sabine Botha, Çağdaş Dağ, Hasan DeMirci |
| 55 |
[GO] |
2022―Jan―20 |
Transcriptome profiling of PBMCs and formalin-fixed autoptic tissues from COVID-19 patients |
Marta Vuerich, Na Wang, Ahmadreza Kalbasi, Jonathon J. Graham, Maria Serena Longhi |
| 56 |
[GO] |
2021―Dec―08 |
Detection of N6-methyladenosine in SARS-CoV-2 RNA by methylated RNA immunoprecipitation sequencing (MeRIP-Seq) |
Na Li, Tariq Rana |
| 57 |
[GO] |
2021―Dec―03 |
Global metabolome profiling of COVID-19 respiratory specimen using High Resolution Mass Spectrometry (HRMS) |
Nupur Sharma, Sadam H. Bhat, Gaurav Tripathi, Manisha Yadav, Babu Mathew, Vasundhra Bindal, Shvetank Sharma, Ekta Gupta, Jaswinder Singh, Shiv Kumar Sarin |
| 58 |
[GO] |
2021―Nov―27 |
Protocol for global proteome, virome, and metaproteome profiling of respiratory specimen (VTM) in COVID-19 patient by LC-MS/MS-based analysis |
Gaurav Tripathi, Nupur Sharma, Vasundhra Bindal, Manisha Yadav, Babu Mathew, Shvetank Sharma, Ekta Gupta, Jaswinder Singh, Shiv Kumar Sarin |
| 59 |
[GO] |
2021―Nov―22 |
Detection of SARS-CoV-2 spike protein binding to ACE2 in living cells by TR-FRET |
Erika Cecon, Julie Dam, Ralf Jockers |
| 60 |
[GO] |
2021―Oct―12 |
Infecting human hematopoietic stem and progenitor cells with SARS-CoV-2 |
Hector Huerga Encabo, Rachel Ulferts, Aneesh Sharma, Rupert Beale, Dominique Bonnet |
| 61 |
[GO] |
2021―Oct―12 |
Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein |
Chao Wu, Abraham J. Qavi, Austin B. Moyle, Nicole D. Wagner, Asmaa Hachim, Niloufar Kavian, Aidan R. Cole, Joyce Sweeney-Gibbons, Henry W. Rohrs, J. S. Malik Peiris, Christopher F. Basler, Michael L. Gross, Sophie A. Valkenburg, Christopher W. Farnsworth, Gaya K. Amarasinghe, Daisy W. Leung |
| 62 |
[GO] |
2021―Sep―27 |
UnCovid: A versatile, low-cost, and open-source protocol for SARS-CoV-2 RNA detection |
Roberto Alcántara, Katherin Peñaranda, Gabriel Mendoza-Rojas, Jose A. Nakamoto, Eva Dueñas, Daniela Alvarez, Vanessa Adaui, Pohl Milón |
| 63 |
[GO] |
2021―Sep―24 |
Computational workflow for functional characterization of COVID-19 through secondary data analysis |
Sudhir Ghandikota, Mihika Sharma, Anil G. Jegga |
| 64 |
[GO] |
2021―Sep―22 |
Identification of SARS-CoV-2 S RBD escape mutants using yeast screening and deep mutational scanning |
Cyrus M. Haas, Irene M. Francino-Urdaniz, Paul J. Steiner, Timothy A. Whitehead |
| 65 |
[GO] |
2021―Sep―13 |
A new flow cytometry assay to measure antibody dependent cellular cytotoxicity against SARS-CoV-2 Spike expressing cells |
Guillaume Beaudoin-Bussières, Jonathan Richard, Jérémie Prévost, Guillaume Goyette, Andrés Finzi |
| 66 |
[GO] |
2021―Aug―27 |
A tissue culture infectious dose (TCID)-derived protocol for testing of SARS-CoV-2 neutralization of serum antibodies on adherent cells |
Fabio Hasler, Agathe Duda, Thomas M. Kündig, Pål Johansen |
| 67 |
[GO] |
2021―Aug―27 |
Application of pseudotyped virus particles to monitor Ebola virus and SARS-CoV-2 viral entry in human cell lines |
Madeleine Eichler, Ebru Aksi, Josef Pfeilschifter, Gergely Imre |
| 68 |
[GO] |
2021―Aug―26 |
An antigen microarray protocol for COVID-19 serological analysis |
Joseph Longworth, Gunnar Dittmar |
| 69 |
[GO] |
2021―Aug―17 |
Fluorogenic in vitro activity assay for the main protease Mpro from SARS-CoV-2 and its adaptation to the identification of inhibitors. |
Ihssen Julian, Faccio Greta, Yao Chunyan, Sirec Teja, Spitz Urs |
| 70 |
[GO] |
2021―Aug―14 |
Optimization of antigen specific CD8+ T cell activation conditions for infectious diseases including COVID-19 |
Chanchan Xiao, Congling Qiu, Jieping Deng, Jiezhou Ye, Lijuan Gao, Jun Su, Oscar Junhong Luo, Pengcheng Wang, Guobing Chen |
| 71 |
[GO] |
2021―Aug―13 |
Luciferase reporter assays to monitor interferon signaling modulation by SARS-CoV-2 proteins |
Maximilian Hirschenberger, Manuel Hayn, Alexandre Laliberté, Lennart Koepke, Frank Kirchhoff, Konstantin Maria Johannes Sparrer |
| 72 |
[GO] |
2021―Aug―02 |
An optimized, amplicon-based approach for sequencing of SARS-CoV-2 from patient samples using COVIDSeq assay on Illumina MiSeq sequencing platforms |
Rahul C. Bhoyar, Vigneshwar Senthivel, Bani Jolly, Mohamed Imran, Abhinav Jain, Mohit Kumar Divakar, Vinod Scaria, Sridhar Sivasubbu |
| 73 |
[GO] |
2021―Jul―10 |
SARS-CoV-2 Spike linear epitope scanning via a peptide microarray through sera profiling |
Yang Li, Dan-yun Lai, Sheng-ce Tao |
| 74 |
[GO] |
2021―Jun―19 |
A flow cytometry-based assay for serological detection of anti-spike antibodies in COVID-19 patients |
Yun Shan Goh, Lisa F.P. Ng, Laurent Renia |
| 75 |
[GO] |
2021―Jun―18 |
Immunohistochemistry for protein detection in PFA-fixed paraffin-embedded SARS-CoV-2 infected COPD airway epithelium. |
Jaspreet Kaur Osan, Beth Ann DeMontigny, Masfique Mehedi |
| 76 |
[GO] |
2021―Jun―09 |
Protein purification and crystallization of HLA-A*02:01 in complex with SARS-CoV-2 peptides |
Demetra S.M. Chatzileontiadou, Christopher Szeto, Dhilshan Jayasinghe, Stephanie Gras |
| 77 |
[GO] |
2021―May―29 |
Protocol for constructing large size human antibody heavy chain variable domain (VH) library and selection of SARS-CoV-2 neutralizing antibody domains |
Chuan Chen, Zehua Sun, Xianglei Liu, Wei Li, Dimiter S. Dimitrov |
| 78 |
[GO] |
2021―May―12 |
Sample processing and single cell RNA-sequencing of peripheral blood immune cells from COVID-19 patients |
Changfu Yao, Stephanie A. Bora, Peter Chen, Helen S. Goodridge, Sina A. Gharib |
| 79 |
[GO] |
2021―May―10 |
A qualitative IgG ELISA for detection of SARS-CoV-2 specific antibodies in Syrian hamster serum samples |
Anita Shete, Sreelekshmy Mohandas, Rajlaxmi Jain, Pragya D. Yadav |
| 80 |
[GO] |
2021―Feb―05 |
Ex vivo assay to evaluate the efficacy of drugs targeting sphingolipids in preventing SARS-CoV-2 infection of nasal epithelial cells |
Katrin Anne Becker, Alexander Carpinteiro, Markus Hoffmann, Stefan Pöhlmann, Johannes Kornhuber, Erich Gulbins |
| 81 |
[GO] |
2021―Feb―05 |
Expression and Purification of Tag-Free SARS-CoV-2 RNA-Dependent RNA Polymerase in Escherichia coli |
Tyler L. Dangerfield, Nathan Z. Huang, Kenneth A. Johnson |
| 82 |
[GO] |
2020―Dec―17 |
Optimized workflow for single-cell transcriptomics on infectious diseases including COVID-19 |
Elena De Domenico, Lorenzo Bonaguro, Jonas Schulte-Schrepping, Matthias Becker, Kristian Händler, Joachim L. Schultze |
| 83 |
[GO] |
2020―Dec―17 |
Glycomics-informed glycoproteomic analysis of site-specific glycosylation for SARS-CoV-2 spike protein |
Katelyn E. Rosenbalm, Michael Tiemeyer, Lance Wells, Kazuhiro Aoki, Peng Zhao |
| 84 |
[GO] |
2020―Nov―09 |
Sensitization of Non-permissive Laboratory Mice to SARS-CoV-2 with a Replication-Deficient Adenovirus Expressing Human ACE2 |
Lok-Yin Roy Wong, Kun Li, Jing Sun, Zhen Zhuang, Jincun Zhao, Paul B. McCray, Stanley Perlman |
| 85 |
[GO] |
2020―Sep―15 |
qRT-PCR Platforms for Diagnosing and Reporting SARS-CoV-2 Infection in Human Samples |
Richard M. Giadone, Aditya Mithal, Gregory J. Miller, Taylor M. Matte, Anthony K. Yeung, Todd W. Dowrey, Rhiannon B. Werder, Nancy S. Miller, Christopher D. Andry, Kim Vanuytsel, George J. Murphy |
